Seminars in Oncology
Volume 31, Issue 6 , Pages 802-808, December 2004

Strategies to overcome accelerated repopulation and hypoxia—what have we learned from clinical trials?

  • June Corry

      Affiliations

    • Head and Neck Radiation Oncology Unit, Division of Radiation Oncology, University of Melbourne, Peter MacCallum Cancer Centre, Melbourne, Australia.
    • ,
  • Danny Rischin

      Affiliations

    • D.R. has acted as a consultant for Sanofi-Synthelabo.
    • Head and Neck Medical Oncology Unit, Division of Haematology and Medical Oncology, University of Melbourne, Peter MacCallum Cancer Centre, Melbourne, Australia.
    • Corresponding Author InformationAddress reprint requests to Danny Rischin, MBBS (Hons), FRACP, Division of Haematology and Medical Oncology, Locked Bag No 1, A’Beckett St, Melbourne, Australia 8006

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0093-7754(04)00402-6

doi:10.1053/j.seminoncol.2004.09.005

Seminars in Oncology
Volume 31, Issue 6 , Pages 802-808, December 2004

Article Tools

* Image Usage & Resolution